Company Profiles

driven by the PitchBook Platform

Amplyx Pharmaceuticals

Description

Operator of molecule drug development company. The company develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics.

2006

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$49.2M

Latest Deal Amount

$53.7M

Total Amount Raised

Description

Operator of molecule drug development company. The company develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics.

Website:

www.amplyx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

3210 Merryfield Row San Diego, CA 92121United States +1 (858) 348-4458
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Amplyx Pharmaceuticals's full profile, request a free trial.

Amplyx Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Amplyx Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Amplyx Pharmaceuticals Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
3x5 Special Opportunity FundVenture CapitalMinority000 0000000 0000
Ariel Southeast Angel PartnersAngel GroupMinority000 0000000 0000
BiobritVenture CapitalMinority000 0000000 0000
BioMed VenturesVenture CapitalMinority000 0000000 0000
Golden SeedsVenture CapitalMinority000 0000000 0000
3x5 Special Opportunity Fund Venture Capital
Ariel Southeast Angel Partners Angel Group
Biobrit Venture Capital
BioMed Ventures Venture Capital
Golden Seeds Venture Capital

Amplyx Pharmaceuticals Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Ciara Kennedy Ph.DChief Operating Officer
Mitchell Mutz Ph.DCo-Founder & Chief Scientific Officer
Gerald Crabtree MDCo-Founder
Karen Shaw Ph.DVice President, Biology
Robert Webb Ph.DVice President, Medicinal Chemistry
Ciara Kennedy Ph.D Chief Operating Officer
Mitchell Mutz Ph.D Co-Founder & Chief Scientific Officer
Gerald Crabtree MD Co-Founder
Karen Shaw Ph.D Vice President, Biology
Robert Webb Ph.D Vice President, Medicinal Chemistry

Amplyx Pharmaceuticals Board Members (3)

NameRepresentingRoleSinceContact
Info
Edward MathersNew Enterprise AssociatesPartner000 0000
Elaine Heron Ph.DAmplyx PharmaceuticalsChairman000 0000
Niall O'Donnell Ph.DRiverVest Venture PartnersManaging Director000 0000
Edward Mathers Partner New Enterprise Associates
Elaine Heron Ph.D Chairman Amplyx Pharmaceuticals
Niall O'Donnell Ph.D Managing Director RiverVest Venture Partners
Request full access to PitchBook